<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02935127</url>
  </required_header>
  <id_info>
    <org_study_id>ER.ALL.2016.02</org_study_id>
    <nct_id>NCT02935127</nct_id>
  </id_info>
  <brief_title>Absorbable Sutures in Vascular Surgery</brief_title>
  <acronym>ASPeVaS</acronym>
  <official_title>Absorbable Sutures in Peripheral Vascular Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Catanzaro</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Catanzaro</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Absorbable sutures are not generally accepted by the majority of vascular surgeons for the&#xD;
      possible complications such as the breakage of the suture at the anastomoses level. Some&#xD;
      experimental and clinical studies in the current literature demonstrated that the use of&#xD;
      absorbable sutures may even reduce some important complications such as restenosis.&#xD;
&#xD;
      The aim of this study is to compare absorbable and non-absorbable sutures in patients&#xD;
      undergoing peripheral vascular surgery with vein bypass grafting.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Infrainguinal vein graft procedures may be performed, generally, on patients with critical&#xD;
      limb ischemia (CLI) or popliteal artery aneurysm (PAA). Autologous vein graft, when adequate&#xD;
      and available, is usually the preferred conduit, especially in the below knee vascular&#xD;
      districts. Vein grafts may complicate with the onset of stenoses (up to 30% of cases). Such&#xD;
      complications may develop, due to myointimal hyperplasia along the body of the graft or, more&#xD;
      often, at the proximal or distal anastomoses where sutures are performed. In vascular surgery&#xD;
      procedures, in case of arterial anastomoses, absorbable suture material is generally not&#xD;
      preferred, mainly for the fear of breakage of the suture line. Previous experimental studies&#xD;
      performed in animals and humans and a recent clinical study performed in humans on carotid&#xD;
      surgery showed that absorbable sutures used in vascular surgery may even reduce the&#xD;
      development of intimal hyperplasia and may reduce postoperative stenotic complications. The&#xD;
      aim of this study is to evaluate the early and long-term results of absorbable sutures used&#xD;
      in peripheral vascular surgery.&#xD;
&#xD;
      This is an open-label, parallel group study.&#xD;
&#xD;
      Patients undergoing vein bass grafting for CLI or PAA may be suitable for entry into ASPeVas&#xD;
      trial. They must satisfy the following inclusion criteria:&#xD;
&#xD;
      Both sex. Age &gt; 18 years old. Patients undergoing femoropopliteal or femorodistal vein bypass&#xD;
      grafting; must be able to give informed consent; have no significant co-morbidity that makes&#xD;
      life expectancy less than six months.&#xD;
&#xD;
      The randomisation process consists as follows: once a patient have consented entering the&#xD;
      trial, an envelop is opened and the patient is offered the type of suture (absorbable or non&#xD;
      absorbable) regardless of the surgical technique which is going to be performed&#xD;
      (femoropopliteal or femorodistal vein bypass grafting).&#xD;
&#xD;
      All patients have to be followed-up, the day after the operation (time 0) and then&#xD;
      subsequently at 1, 3,6,9,12 and 18 months.&#xD;
&#xD;
      At each appointment, Ankle Brachial Pressure Index (ABPI) is measured and then Duplex&#xD;
      scanning (DS) is performed. In particular, by means of DS the peak systolic flow velocity&#xD;
      (PSFV) at multiple sites along the entire graft is measured. A graft at risk of failure was&#xD;
      defined as having a PSFV &lt; 45 cm/s or a ratio of V2 (peak velocity at the site of the&#xD;
      stenosis) to V1 (peak systolic velocity at any other point within 2 cm at the normal adjacent&#xD;
      graft) &gt; 2. Any other irregularities, such as inflow/outflow problems, graft dilatation will&#xD;
      be also recorded.&#xD;
&#xD;
      Clinical signs of a failing graft will be collected: disabling claudication, ischemic pain,&#xD;
      ischemic ulcers.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Flow Velocity in the graft</measure>
    <time_frame>18 months</time_frame>
    <description>centimeters per second (cm/sec)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Peripheral Vascular Disease</condition>
  <arm_group>
    <arm_group_label>Absorbable Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this group of patients absorbable sutures will be used for vascular anastomoses.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-Absorbable Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this group of patients non-absorbable sutures will be used for vascular anastomoses.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Absorbable suture</intervention_name>
    <description>Vascular anastomoses will be performed with absorbable materials</description>
    <arm_group_label>Absorbable Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Non-Absorbable suture</intervention_name>
    <description>Vascular anastomoses will be performed with non-absorbable materials</description>
    <arm_group_label>Non-Absorbable Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        inclusion criteria:&#xD;
&#xD;
          -  Patients undergoing femoropopliteal or femorodistal vein bypass grafting;&#xD;
&#xD;
          -  Patients able to give informed consent;&#xD;
&#xD;
          -  Patients having no significant co-morbidity that makes life expectancy less than six&#xD;
             months.&#xD;
&#xD;
        exclusion criteria:&#xD;
&#xD;
          -  patients that do not meet the aforementioned criteria.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raffaele Serra, M.D., PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Magna Graecia of Catanzaro</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stefano de Franciscis, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>University Magna Graecia of Catanzaro</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Raffaele Raffaele, Raffaele</last_name>
    <phone>+393387078043</phone>
    <email>rserra@unicz.it</email>
  </overall_contact>
  <reference>
    <citation>Gasbarro V, Traina L, Mascoli F, Coscia V, Buffone G, Grande R, Fugetto F, Butrico L, de Franciscis S, Serra R. Absorbable suture material in carotid surgery. Vasa. 2015 Nov;44(6):451-7. doi: 10.1024/0301-1526/a000468.</citation>
    <PMID>26515222</PMID>
  </reference>
  <verification_date>October 2016</verification_date>
  <study_first_submitted>October 13, 2016</study_first_submitted>
  <study_first_submitted_qc>October 13, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 17, 2016</study_first_posted>
  <last_update_submitted>October 13, 2016</last_update_submitted>
  <last_update_submitted_qc>October 13, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Catanzaro</investigator_affiliation>
    <investigator_full_name>Prof. Raffaele Serra, MD, Ph.D.</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>absorbable sutures</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

